Skip to main content

Table 2 Relationship between serum miR-135 and miR-20a expression and clinical characteristics in patients with gastric cancer [(‾χ ± s), U/mL]

From: Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer

Clinical characteristic Cases (n) miR-135 expression P miR-20a expression P
Gender    > 0.05   > 0.05
 M 97 7.56 ± 0.57   6.56 ± 0.85  
 F 49 7.43 ± 0.54   6.48 ± 0.83  
Age (years)    > 0.05   > 0.05
 < 60 88 7.98 ± 0.67   6.64 ± 0.76  
 ≥ 60 58 8.16 ± 0.69   6.72 ± 0.81  
Degree of gastric cancer progression    < 0.01   < 0.01
 Early stage 54 7.96 ± 0.32   5.08 ± 0.46  
 Progressive phase 92 9.11 ± 0.34   7.23 ± 0.41  
TNM stage    < 0.01   < 0.01
 I-II 76 7.24 ± 0.26   4.93 ± 0.37  
 III-IV 70 9.36 ± 0.28   7.51 ± 0.42  
Degrees of differentiation    < 0.01   < 0.01
 Well differentiated 94 7.78 ± 0.34   5.56 ± 0.42  
 Poorly differentiated 52 9.36 ± 0.41   7.38 ± 0.47  
Lymph node metastasis    < 0.01   < 0.01
 No 65 7.43 ± 0.27   5.13 ± 0.49  
 Yes 81 9.27 ± 0.32   7.44 ± 0.46  
Distant metastasis    < 0.01   < 0.01
 Yes 53 7.51 ± 0.45   5.34 ± 0.66  
 No 93 9.43 ± 0.53   7.63 ± 0.72